Hematology Biobank for Blood Disorders
This study is creating a biobank, which is like a library of blood samples, from people with different hematological disorders (blood conditions). Researchers want to collect blood samples and medical information to better understand these conditions. You might be able to join if you are over 12 years old, are a patient at Montefiore-Einstein, and are being cared for by a Montefiore-Einstein hematologist for a blood disorder. The goal is to have this biobank available for future research for at least 5 years, which will help scientists learn more about blood disorders. The current status of this study is unclear.
- Study design
- This is an observational study aiming to enroll 2000 participants. It is collecting blood samples and medical histories to create a biobank.
- What's involved
- Blood samples will be collected, either from leftover samples from routine care or by specifically donating 1-5 tubes (3-20 ml) of blood, often during a regular visit.
- Compensation
- Not stated in the trial record.
- Follow-up
- The biobank is planned to be maintained for 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Hematology Biobank: In Vitro Study of Blood Disorders
At a glance
Conditions
NCT02442011
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Montefiore Medical Center
The Bronx, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Henny Billett · PRINCIPAL_INVESTIGATOR · Albert Einstein College of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Biobank5 years
To have specimens available for IRB approved studies